Clinical efficacy of combination of pertuzumab, trastuzumab, and docetaxel for treatment of patients with HER2-positive breast cancer
Conclusion:
This study will provide efficacy and safety of PTD for HER2-PBC.
Source: Medicine - Category: Internal Medicine Tags: Research Article: Study Protocol Systematic Review Source Type: research
More News: Alternative and Complementary Therapies | Breast Cancer | Cancer | Cancer & Oncology | China Health | Complementary Medicine | Databases & Libraries | Docetaxel | HER2 | Herceptin | Internal Medicine | Science | Statistics | Study | Taxotere | Toxicology